Edoxaban versus warfarin in patients with atrial fibrillation

Keyphrases

• Atrial Fibrillation 100%
• Warfarin 100%
• Edoxaban 100%
• Confidence Interval 83%
• Hazard Ratio 83%
• High Dose 25%
• Non-inferiority 25%
• Systemic Embolism 25%
• Once-daily Regimen 16%
• Major Bleeding 16%
• Randomized Double-blind 8%
• High Risk 8%
• Bleeding 8%
• Intention-to-treat Analysis 8%
• Death Rate 8%
• Treatment Duration 8%
• Double Dummy 8%
• Time in Therapeutic Range 8%
• Low Dose Rate 8%
• Median Time 8%
• Direct Oral 8%
• Pharma 8%
• Long-term Safety 8%
• Oral Factor Xa Inhibitors 8%
• Daiichi 8%
• Long-term Efficacy 8%
• ENGAGE AF-TIMI 48 8%
• Antithrombotic Effect 8%
• Stroke Prevention 8%

Pharmacology, Toxicology and Pharmaceutical Science

• Warfarin 100%
• Atrial Fibrillation 100%
• Edoxaban 100%
• Bleeding 25%
• Cerebrovascular Accident 25%
• Anticoagulant Agent 8%
• Blood Clotting Factor 10a Inhibitor 8%